Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any progressive external ophthalmoplegia with mitochondrial DNA deletions in which the cause of the disease is a mutation in the POLG2 gene.
Features include always present findings: Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Left bundle branch block, Cytochrome C oxidase-negative muscle fibers, and Exercise intolerance and others; and sometimes findings: Shrinkage of the cerebellum (cerebellar atrophy), Seizure, Abnormality of the liver, and Low muscle tone (hypotonia) and others. 28 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 7 | Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia), Generalized hypotonia |
Digestive system | 5 | Abnormality of the liver, Gastroesophageal reflux, Constipation |
Brain and nerves | 4 | Seizure, Cerebral visual impairment, Exercise intolerance |
Lab test results | 3 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Elevated circulating hepatic transaminase concentration, Increased circulating lactate concentration |
Heart and blood vessels | 3 | Arrhythmia, Left bundle branch block, Ventricular bigeminy |
Eyes | 2 | Cerebral visual impairment, Ptosis |
Head and neck | 1 | Facial palsy |
Arms and legs | 1 | Limb muscle weakness |
Growth and development | 1 | Failure to thrive |
POLG2 function has not been fully characterized.
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 is associated with mutations in the POLG2 gene on chromosome 17.
Genetic testing for POLG2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 8 always present features.
No clinical trials have been registered for progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4.
1 publication has been identified in PubMed for progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4. Research spans Case Report / Case Series (100%).
Rossi V (2025). [PMID: 40631390](https://pubmed.ncbi.nlm.nih.gov/40631390/). *Am J Med Genet A*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 5:41 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center